<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A variety of reduced-intensity conditionings have been used in the reported studies of allogeneic hematopoietic stem cell transplantation (HSCT) for elderly patients with myeloid <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This study retrospectively analyzed the outcome of allogeneic HSCT for 10 patients aged 50 years or older with myeloid <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> after conditioning with fludarabine (125 mg/m(2)), melphalan (140 mg/m(2)) and total body irradiation (TBI; 8 Gy) </plain></SENT>
<SENT sid="2" pm="."><plain>Median age of the patients was 56.5 years, and diagnoses included <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo>, advance <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, and secondary <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Sources of stem cells were bone marrow from sibling (n=4) or unrelated donor (n=6) </plain></SENT>
<SENT sid="4" pm="."><plain>Both overall and disease-free survival rates were 40.0% (95% CI: 10.6~69.4%) </plain></SENT>
<SENT sid="5" pm="."><plain>Causes of <z:hpo ids='HP_0011420'>death</z:hpo> were relapse (n=2), <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infection</z:e> (n=2), and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary malignancies</z:e> (n=2) </plain></SENT>
<SENT sid="6" pm="."><plain>Because of a high incidence of transplant-related mortality, further refinement of this conditioning is required </plain></SENT>
</text></document>